The goal of this project is to prove that commercial production of regenerative proteins can be made consistently and with a significant cost…
See where grants have been awarded across Minnesota.
Troy C. Lund, MD, PhD
Successful bone marrow transplant is the only way to cure a number of cancers, bone marrow failure syndromes, and other serious blood disease (like…
2018-2020
Hereditary Tyrosinemia Type 1 (HT1) is a genetic disorder that can lead to liver and kidney failure, and is fatal without treatment. There is no…
2018-2020
Cardiovascular disease is the most common cause of death in the United States, and many patients need heart transplants to survive. Currently,…
2018-2020
The decline of memory and thinking processes seen in aging, neurodegenerative diseases (like Alzheimer’s disease), and exposure of the brain to…
2018-2020
Each year in the United States, 12,000 extremely preterm infants (birth before 28 weeks of pregnancy) develop bleeding within the brain soon after…
2018-2020
Millions of U.S. citizens suffer from vein valve insufficiency, often resulting in chronic leg ulcers that cause pain, immobility, and a reduced…
2018-2020
Spinocerebellar ataxia type 1 (SCA1) is a fatal neurodegenerative disease with no available therapies. This proposal will determine therapeutic…
2018-2020
The goal of this project is to develop microcapsules that could be used as cell carriers during differentiation of stem cells into pancreatic…
2018-2020
The major challenge in treating obesity is not just losing weight, but preventing weight from coming back. This proposal examines a new treatment…
2018-2019
This clinical trial investigates whether adipose-derived (fat tissue-derived) mesenchymal stem cells can be safely administered into the…
2018-2020
Many regenerative therapies are based on using a patient’s own cells to create induced pluripotent stem (iPS) cells that can then be differentiated…
2018-2020